Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma.
about
Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@en
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@nl
type
label
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@en
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@nl
prefLabel
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@en
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@nl
P2093
P2860
P1476
Angiopoietin-2 inhibition usin ...... tivity in human neuroblastoma.
@en
P2093
Bharathi P Salimath
Karine Scherzinger-Laude
Marc Simon
Saritha Sandra D'Souza
P2860
P2888
P304
P356
10.1007/S00432-012-1282-3
P577
2012-07-10T00:00:00Z